The Management and Outcome of Invasive/In Situ Cervical Carcinoma and cervical dysplasia
Dr. Jayanthi Lea and Dr. Miller, and his staff of the Division of Gynecologic oncology will review medical records of patients diagnosed with invasive cervical carcinoma and cervical dysplasia at uT Southwestern Medical Center at Dallas. They will identify and retrospectively review medical records for patients treated with invasive/in situ cervical carcinoma and cervical dysplasia at uT Southwestern Medical Center at Dallas and Parkland Hospital. identification of patients will be from the tumor registry, medical records and pathology databases. Clinical and pathological patient data, including Demographics (MRn, DoB, race weight), Diagnosis (date, disease stage, sites of disease, size of disease), clinical variables, operative findings, pathologic findings, Toxicity, Dosimetric data/ (critical organ volumes and planned dose, dose deformation ), length of treatment (including delays), epic reports of toxicity data, Chemotherapy and Radiation details form Registry will be obtained and a single spreadsheet will be filled out for each patient. Dr. Lea, Dr. Miller and his staff will be responsible for transferring the clinical and pathologic information to a database. Dr. Lea and Dr. Miller and his staff will be responsible for storing the spreadsheets in a locked cabinet of a locked office. Dr, Lea and Dr. Miller and his staff will be the sole investigators having access to identifying patient information. all patient names and medical record numbers will be entered into a database until data collection is completed, at which time all identifiers will be destroyed.
All patients diagnosed with invasive/in situ cervical carcinoma from January 1982 until June 2016 will have their records reviewed.